ID

17835

Beskrivning

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains the Pharmacogenetic and Pharmacogenomic Research.

Nyckelord

Versioner (2)
  1. 2016-10-04 2016-10-04 -
  2. 2016-12-05 2016-12-05 -
Uppladdad den

4 oktober 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

Engelsk

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 Formulär  
General Information
Beskrivning

General Information

Protocol Identifier: AVA100193
Beskrivning

Protocol Identifier

Datatyp

boolean

Subject Identifier
Beskrivning

Subject Identifier

Datatyp

integer

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Beskrivning

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research

Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
Beskrivning

Informed Consent

Datatyp

boolean

If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
Beskrivning

Date

Datatyp

date

If no, select one reason
Beskrivning

Reason for not obtaining informed consent

Datatyp

text

If Other, please specify
Beskrivning

Specification of Other

Datatyp

text

Blood sample collection (DNA)
Beskrivning

Blood sample collection (DNA)

Has a blood sample been collected for PGx-pharmacogenetic research?
Beskrivning

Has a blood sample been collected for PGx-pharmacogenetic research?

Datatyp

boolean

If yes, record the date samples taken.
Beskrivning

Date

Datatyp

date

Withdrawal of consent
Beskrivning

Withdrawal of consent

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Beskrivning

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?

Datatyp

boolean

Blood sample Destruction
Beskrivning

Blood sample Destruction

Has a request been made for sample destruction?
Beskrivning

Has a request been made for sample destruction?

Datatyp

boolean

If yes, specify reason
Beskrivning

If yes, specify reason

Datatyp

text

If other, please specify
Beskrivning

Other

Datatyp

text

Alias
UMLS CUI [1]
C0205394
Tillbaka till toppen

Similar models

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
General Information
Protocol Identifier
Item
Protocol Identifier: AVA100193
boolean
Subject Identifier
Item
Subject Identifier
integer
Item Group
PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Informed Consent
Item
Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
boolean
Date
Item
If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
date
Item
If no, select one reason
text
Reason for not obtaining informed consent
Code List
If no, select one reason
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator  (2)
CL Item
Other (specify) (3)
Specification of Other
Item
If Other, please specify
text
Item Group
Blood sample collection (DNA)
Has a blood sample been collected for PGx-pharmacogenetic research?
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
Date
Item
If yes, record the date samples taken.
date
Item Group
Withdrawal of consent
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Item
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
boolean
Item Group
Blood sample Destruction
Has a request been made for sample destruction?
Item
Has a request been made for sample destruction?
boolean
Item
If yes, specify reason
text
If yes, specify reason
Code List
If yes, specify reason
CL Item
Subject requested (1)
CL Item
Other (specify) (2)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial